Sign up today and save up to 83% on a Hartford Courant digital subscription
CT Now

FDA approves reverse-anticoagulant drug Kcentra

When patients medicated for atrial fibrillation are brought to emergency departments with severe bleeding, reversing the effects of the anticoagulants they take can be difficult. The FDA has just approved a new product, Kcentra, for this purpose in some patients. Lawrence K. Ho
This photo is featured in these articles:
Loading
77°